A 67-year-old man with a history of type 2 diabetes, diabetic peripheral neuropathy, and hypertension presents to the emergency department with a skin ulceration on the bottom of his great toe ...

FibroBiologics Inc. FBLG on Tuesday said it completed manufacturing of the first batch of FibroBiologics' proprietary CYWC628 drug product that will support upcoming first-in-human clinical trials.

Pemafibrate was tied to potential prevention of leg and foot ulcers in type 2 diabetes, a silver lining to the PROMINENT trial's otherwise disappointing cardiovascular results. In an exploratory ...

FibroBiologics completed manufacturing the first batch of its proprietary CYWC628 drug product that will support upcoming first-in-human clinical trials. The clinical-stage biotech company said ...

There are various ways of classifying diabetic foot ulcers (DFUs). Some guidelines refer to a staged system ranging from stage 1 — no symptoms and no risk — to stage 6, where treatment can no longer ...

CLEVELAND, Ohio— Cleveland-based biotechnology company Discovery Therapeutics Caribe will soon be studying a treatment for diabetic ulcers that was developed in Cuba. The drug, which helps close ...

Foot health represents one of the most critical yet frequently overlooked aspects of diabetes management. The combination of vascular changes and nerve damage that often accompanies type 2 diabetes ...

Background Diabetic foot is an infection, ulceration or destruction of the tissue of the foot of a person diagnosed with diabetes mellitus (DM). Diabetic foot ulcer (DFU) is a major and preventable ...

Diabetic foot is a serious, common condition that affects about half of those with diabetes. Key symptoms of diabetic foot include tingling and numbness in the feet, calluses, and peeling skin.

You probably check your feet for cuts, blisters, or fungal infections, but there’s an unusual warning sign hiding in your feet that could indicate developing diabetes long before your blood sugar ...